MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2025 | 19.75 M | $771.68 M | 0.00% | 31.24% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 8.49 M | $331.87 M | 0.00% | 13.43% |
| FMR LLC | 05/12/2025 | 6.33 M | $247.20 M | -0.23% | 10.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 2.97 M | $116.19 M | -11.06% | 4.70% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 2.77 M | $108.23 M | 0.00% | 4.38% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.48 M | $57.77 M | -32.39% | 2.34% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 05/09/2025 | 1.43 M | $56.06 M | 9.39% | 2.27% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.29 M | $50.50 M | -22.81% | 2.04% |
| FEDERATED HERMES, INC. | 05/08/2025 | 1.27 M | $49.59 M | -0.84% | 2.01% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 1.10 M | $42.98 M | 0.00% | 1.74% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 966.09 K | $37.75 M | -5.53% | 1.53% |
| 05/12/2025 | 673.34 K | $26.31 M | 100.00% | 1.06% | |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 662.98 K | $25.90 M | 2.06% | 1.05% |
| FRED ALGER MANAGEMENT, LLC | 05/16/2025 | 642.88 K | $25.12 M | -4.58% | 1.02% |
| MARSHALL WACE, LLP | 05/15/2025 | 640.92 K | $25.04 M | -48.53% | 1.01% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 627.42 K | $24.51 M | -64.60% | 0.99% |
| CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 441.00 K | $17.23 M | 0.00% | 0.70% |
| FINEPOINT CAPITAL LP | 05/14/2025 | 435.79 K | $17.03 M | -2.71% | 0.69% |
| VOYA INVESTMENT MANAGEMENT LLC | 06/18/2025 | 392.92 K | $15.35 M | -12.46% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 344.32 K | $13.45 M | 100.00% | 0.54% |
| SATURN V CAPITAL MANAGEMENT LLC | 05/15/2025 | 343.85 K | $13.43 M | -0.65% | 0.54% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 322.11 K | $12.58 M | -7.07% | 0.51% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 316.05 K | $12.35 M | 0.26% | 0.50% |
| WOODLINE PARTNERS LP | 05/15/2025 | 296.15 K | $11.57 M | 0.89% | 0.47% |
| OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 296.00 K | $11.56 M | 100.00% | 0.47% |
| BLACKROCK, INC. | 05/02/2025 | 286.21 K | $11.18 M | -22.40% | 0.45% |
| VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 258.15 K | $10.09 M | 44.62% | 0.41% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 216.90 K | $8.47 M | -17.10% | 0.34% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 201.52 K | $7.87 M | -1.40% | 0.32% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2025 | 200.00 K | $7.81 M | 0.00% | 0.32% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 200.00 K | $7.81 M | 100.00% | 0.32% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 191.50 K | $7.48 M | 100.00% | 0.30% |
| HOLOCENE ADVISORS, LP | 05/15/2025 | 188.99 K | $7.38 M | -88.08% | 0.30% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 179.20 K | $7.00 M | 100.00% | 0.28% |
| CANDRIAM S.C.A. | 05/14/2025 | 174.52 K | $6.82 M | -23.28% | 0.28% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 142.22 K | $5.56 M | 4.24% | 0.22% |
| CAPTION MANAGEMENT, LLC | 05/15/2025 | 138.60 K | $5.42 M | 100.00% | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 137.52 K | $5.37 M | 23.74% | 0.22% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 124.90 K | $4.88 M | -12.47% | 0.20% |
| UBS GROUP AG | 05/13/2025 | 120.77 K | $4.72 M | 332.58% | 0.19% |
| 05/15/2025 | 114.62 K | $4.48 M | 100.00% | 0.18% | |
| VANGUARD GROUP INC | 05/09/2025 | 114.02 K | $4.45 M | -1.21% | 0.18% |
| AXA S.A. | 05/15/2025 | 104.04 K | $4.06 M | -0.13% | 0.16% |
| HARBOR CAPITAL ADVISORS, INC. | 04/14/2025 | 102.02 K | $3.99 M | 28.09% | 0.16% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 94.50 K | $3.69 M | 100.00% | 0.15% |
| STATE STREET CORP | 05/15/2025 | 93.40 K | $3.65 M | 2.02% | 0.15% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 91.17 K | $3.56 M | 100.21% | 0.14% |
| JANE STREET GROUP, LLC | 05/19/2025 | 90.80 K | $3.55 M | 650.41% | 0.14% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 80.00 K | $3.13 M | 966.67% | 0.13% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 78.84 K | $3.08 M | -61.84% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics institutional Ownership - FAQ's
During the previous two years, 154 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 19.75 M
Cormorant Asset Management, LP: 8.49 M
FMR LLC: 6.33 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.97 M
Avoro Capital Advisors LLC: 2.77 M
CITADEL ADVISORS LLC: 1.48 M
93.45% of MoonLake Immunotherapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 60.45 M shares in the last 24 months. This purchase volume represents approximately $2.96 B in transactions.